Atlas Trials

Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)

Clinical trial NCT04979130 · COMPLETED

Trial details

NCT number
NCT04979130
Sponsor
University of Colorado, Denver
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 DiabetesChronic InflammationIntestinal Permeability
Start date
2022-01-01
Primary completion
2024-10-16
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.